Skip to main content
TipRanks
Go Ultimate75% OFF

Hangzhou Tigermed Consulting Co., Ltd. Class H (3347) Stock Statistics & Valuation Metrics

4 Followers

Total Valuation

Hangzhou Tigermed Consulting Co., Ltd. Class H has a market cap or net worth of HKD 39.88B. The enterprise value is HKD 43.47B.

Market Cap
HKD 39.88B
Enterprise Value
HKD 43.47B

Share Statistics

Hangzhou Tigermed Consulting Co., Ltd. Class H has 123,124,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
123,124,800
Owned by Insiders
―
Owned by Institutions
15.43%

Financial Efficiency

Hangzhou Tigermed Consulting Co., Ltd. Class H’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 3.11%.

Return on Equity (ROE)
0.04
Return on Assets (ROA)
0.03
Return on Invested Capital (ROIC)
3.11%
Return on Capital Employed (ROCE)
0.04
Revenue Per Employee
613.91K
Profits Per Employee
79.77K
Employee Count
11,130
Asset Turnover
0.24
Inventory Turnover
119.50

Valuation Ratios

The current PE Ratio of Hangzhou Tigermed Consulting Co., Ltd. Class H is -97.83. Hangzhou Tigermed Consulting Co., Ltd. Class H’s PEG ratio is 0.58.

PE Ratio
-97.83
PS Ratio
4.52
PB Ratio
1.99
Price to FCF
30.97
Price to Operating Cash Flow
30.56
PEG Ratio
0.58

Income Statement

In the last 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H had revenue of 6.83B and earned 887.89M in profits. Earnings per share was 1.03.

Revenue
6.83B
Gross Profit
1.87B
Operating Income
1.01B
Pretax Income
1.00B
Net Income
887.89M
EBITDA
1.42B
Earnings Per Share (EPS)
1.03

Cash Flow

In the last 12 months, operating cash flow was 1.29B and capital expenditures -172.68M, giving a free cash flow of 1.12B billion.

Operating Cash Flow
1.29B
Free Cash Flow
1.12B
Free Cash Flow per Share
1.33

Dividends & Yields

Hangzhou Tigermed Consulting Co., Ltd. Class H pays an annual dividend of HKD 0.32, resulting in a dividend yield of 0.41%

Dividend Per Share
HKD 0.32
Dividend Yield
0.41%
Payout Ratio
41.18%
Free Cash Flow Yield
3.17%
Earnings Yield
-1.01%

Stock Price Statistics

Beta
1.02
52-Week Price Change
-20.11%
50-Day Moving Average
42.09
200-Day Moving Average
39.94
Relative Strength Index (RSI)
33.00
Average Volume (3m)
1.47M

Important Dates

Hangzhou Tigermed Consulting Co., Ltd. Class H upcoming earnings date is Mar 29, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 29, 2026
Next Earnings Date
Mar 29, 2027
Ex-Dividend Date
Jun 12, 2025

Financial Position

Hangzhou Tigermed Consulting Co., Ltd. Class H as a current ratio of 2.18, with Debt / Equity ratio of 7.04%

Current Ratio
2.18
Quick Ratio
2.16
Debt to Market Cap
0.03
Net Debt to EBITDA
-0.21
Interest Coverage Ratio
11.15

Taxes

In the past 12 months, Hangzhou Tigermed Consulting Co., Ltd. Class H has paid 198.16M in taxes.

Income Tax
198.16M
Effective Tax Rate
0.20

Enterprise Valuation

Hangzhou Tigermed Consulting Co., Ltd. Class H EV to EBITDA ratio is 23.61, with an EV/FCF ratio of 31.52.

EV to Sales
4.60
EV to EBITDA
23.61
EV to Free Cash Flow
31.52
EV to Operating Cash Flow
27.29

Balance Sheet

Hangzhou Tigermed Consulting Co., Ltd. Class H has HKD 2.12B in cash and marketable securities with HKD 2.10B in debt, giving a net cash position of HKD 21.82M billion.

Cash & Marketable Securities
HKD 2.12B
Total Debt
HKD 2.10B
Net Cash
HKD 21.82M
Net Cash Per Share
HKD 0.18
Tangible Book Value Per Share
HKD 23.62

Margins

Gross margin is 25.80%, with operating margin of 8.58%, and net profit margin of -5.32%.

Gross Margin
25.80%
Operating Margin
8.58%
Pretax Margin
-2.76%
Net Profit Margin
-5.32%
EBITDA Margin
19.50%
EBIT Margin
15.90%

Analyst Forecast

The average price target for Hangzhou Tigermed Consulting Co., Ltd. Class H is HKD 49.90, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
HKD 49.90
Price Target Upside
41.44% Upside
Analyst Consensus
Moderate Buy
Analyst Count
3
Revenue Growth Forecast
21.72%
EPS Growth Forecast
-169.67%

Scores

Smart Score
6
AI Score
55